Objective: To study the association between systemic fungal infection (SFI) and the development of retinopathy of prematurity (ROP) and severe ROP in very low birth weight (VLBW) infants by systematic review and meta-analysis.
Introduction
With increasing survival of very low birth weight (VLBW) premature infants, morbidities in these babies are increasing. 1, 2 Infection is a major cause of mortality and morbidity among VLBW infants (birth weight <1500 g). 3, 4 Systemic candidiasis has become increasingly important as a cause of infection in VLBW infants. [5] [6] [7] Neonatal candidemia occurs in 1.6 to 9% of VLBW infants 1,2 and 4 to 15% in extremely low birth weight infants (ELBW; birth weight <1000 g), with the 30-day mortality approaching 40%. 1, 4, [8] [9] [10] [11] The occurrence of candidemia has been reported as an independent risk factor associated with development of retinopathy of prematurity (ROP) [12] [13] [14] [15] [16] [17] and ROP requiring laser surgery. 12 Yet others 18 have found such an association only in a univariate analysis but not in a multiple logistic regression model.
Objective of this study was to investigate the association between systemic fungal infection (SFI) and development of all degrees of ROP and severe ROP in VLBW infants by a meta-review of the medical literature and provide clinicians the weight of the cumulative evidence.
Methods

Literature search
A comprehensive search of electronic databases including MEDLINE (1966 to 08/2006), EMBASE (1980 to the third quarter of 2006) and Scopus using relevant search terms (infant, very/ extremely low birth weight, 'extremely low birth weight', infant, premature, candida/albicans/tropicalis/glabrata, candidiasis, 'systemic fungal infection', candidemia, candidiasis, candida sepsis, fungemia, 'fungal sepsis', 'invasive candidiasis', 'retinopathy of prematurity', 'severe ROP' or 'severe retinopathy of prematurity', retinal detachment, 'retrolental fibroplasia', 'threshold rop', 'threshold retinopathy of prematurity') was done. The host for the search was Ovid r (2000 to 2006 Ovid r Technologies Inc., version: rel10.3.2, source ID 1.12052.1.159). The search was carried out by an information specialist (librarian who is trained and specializes in comprehensive electronic database searches) and one of the reviewers (SKB). Authors were contacted for clarification of data from three studies and all of them responded. A daily auto alert for MEDLINE, Ovid MEDLINE in process and other nonindexed citations and EMBASE was set on Ovid for any new articles that are added to these databases using the search strategy outlined above. Search words were introduced with suffix mp. (mp ¼ title, original title, abstract, name of substance word, subject heading word) and were also 'exploded' (a function that expands the search strategy to incorporate a term and its more specific terms and allows multiple subject headings to be searched together). Combination strategies with Boolean operators and/or were used.
Raw data of two studies from the same institution were used to avoid duplication as their study periods overlapped. 12, 16 Data were analyzed with Review Manager 4.2 software (Nordic Cochrane Center, Cochrane Collaboration, Kbehavn, Denmark). A fixed effects meta-analysis model was used in this review because the combination of treatment effect estimates across studies incorporates an assumption that the studies are each estimating exactly the same quantity. Peer-reviewed articles that contained a well-described population of either all admissions to a neonatal intensive care unit (NICU) or all neonates from a NICU who had at least one positive blood culture for candida or other fungi were included. Cohort studies were defined to be studies in which the authors initiated a prospective study to ascertain risk factors related to candidemia or complications from candidemia for a presubscribed period of time; and case-control studies were defined as those that identified cases of ROP and severe ROP and similar matched controls without ROP/severe ROP and then looked back in time to see the relevant exposures, including SFI and no SFI. Articles that included patients who were not neonates, case series and overlap patients from previous articles, so as not to count the same patients several times, were excluded. Additional information was found by following the reference citations from retrieved articles. Conference proceedings were searched. There were no efforts to identify unpublished studies. We did not check print versions of electronic databases as these studies were generally done after the mid 1970s and should be covered by the electronic databases from 1966 onward.
Only articles in the English language were chosen. Crossreferences of articles were checked. No hand searching was done. The systematic review is presented in the format suggested by the consensus statement of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. 19 Study selection All studies considered were retrospective cohort studies. Case series, case reports, review articles, ideas, opinions, letters and editorials were not considered, as they did not have control groups for comparison. Data extracted for the outcome of all ROP were the number of patients with/without all degrees of ROP in the SFI group and also the number of patients with/without all degrees of ROP in the non-SFI group. Similar data were extracted for the outcome of severe ROP. StageX3 was considered severe ROP. The cases and control groups in each of the studies were closely matched and the internal validity of the data was present in half of the studies and was either absent 12 or not available in others. 16, 17, 20 Raw data of two studies 12, 16 from the same institution were combined to avoid duplication as their study periods overlapped and had a total of 185 patients including 133 patients from the study by Mittal et al.
12
Data extraction
We developed a template of 2 Â 2 tables for data abstraction before review to increase reliability. Two reviewers (SKB and RD) independently abstracted the results. When differences occurred, the reviewers discussed the disparity and came to a consensus. The following information was abstracted from each included study: first author, total number of patients in each group i.e. with SFI and no SFI, those that had the outcome of all ROP/severe ROP vs those that did not have the outcome of all ROP/severe ROP and type of study and the year that the study was conducted and published.
Data transformation and analysis
Results and effect sizes analyzed with Review Manager 4.2. software are expressed as relative risk (RR), odds ratio (OR), risk difference (RD) and number needed to harm (NNH) with 95% confidence intervals. I 2 and w 2 -tests were performed.
, where Q is the w 2 -statistic and d.f. is its degrees of freedom. 21, 22 This describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error (chance). A value greater than 50% may be considered substantial heterogeneity. Tests for overall effect are expressed as Z-scores and P-values. We also tested for publication bias using funnel plots.
Results
A total of 27 studies were found after a comprehensive search of EMBASE, MEDLINE and Scopus. We excluded duplicates, case series, articles not including neonates, review articles and articles not relevant to the systematic review. Finally, seven studies plus an abstract, all retrospective cohort studies, were found by both the authors and were included for analysis in this review. [12] [13] [14] [15] [16] [17] [18] 20 The characteristics of these studies are presented in Table 1 . There were many similarities and differences in the studies. The similarities were that all of the studies used the International Classification of ROP to stage the severity of ROP and they were all retrospective cohort studies. There were also differences among studies. All patients included were only ELBW in some studies 12, [15] [16] [17] [18] 20 but VLBW and ELBW in others. 13, 14 Also, all studies expressed their central tendency and measures of dispersion as mean ± standard deviation except one which expressed it as median and range. 18 In addition, all studies addressed the exposures of SFI alone except some that studied bacterial sepsis in addition to SFI 13, 17 and others that studied the effect of race 16 on ROP. The outcomes studied were ROP and threshold ROP in all except one that studied in addition to ROP, other short-term morbidity and long-term neurodevelopmental outcomes. 20 Classification of SFI was done differently by different studies. Some studies 12,14,16 -18 defined candida sepsis as positive blood culture for candida. Others 15 defined fungal sepsis as positive blood culture for candida with clinical signs of sepsis. Still others 13 defined SFI as positive candida culture from (1) blood withdrawn from peripheral sites; (2) urine collected by suprapubic sterile puncture or sterile bladder catheterization, with growth of more than 10 000 fungal organisms per ml; (3) cerebrospinal fluid or (4) intravascular catheter tip (but only limited to patients with prior colonization by the same species; otherwise, positivity was considered as colonization). One study 20 defined candida sepsis as positive blood culture for candida and candida meningoencephalitis if a CSF culture was positive for candida, if brain autopsy supported a diagnosis of disseminated candidiasis or if multiple parenchymal hyperechoic lesions were detected by cranial ultrasound along with a positive blood culture for candida. All studies except one 15 had patients with candidemia; in that study 5 of 14 patients had non-candida fungemia (two had Malassezia furfur and three had M. pachydermatis). ROP was classified and staged by the International Classification of ROP. 23 All studies were retrospective cohort studies. Inclusion criteria were available for all studies and exclusion criteria were available for all except one. 17 Internal validity of the data was present in half of the studies and was either absent 12 or not available in others. 16, 17, 20 Data on infants with severe ROP were available from eight studies [12] [13] [14] [15] [16] [17] [18] 20 and for all ROP were available from seven of those eight studies. [12] [13] [14] [15] [16] [17] [18] Friedman et al. 20 only included babies with severe ROP but not for any ROP.
All ROP A total of 261 of 303 babies with SFI had all degrees of ROP compared to 1081 of 1648 babies with no SFI. The risk of all ROP was significantly higher in the group that had SFI compared to the group that had no SFI (Figure 1 ). For VLBW infants, typical OR 3.4* (2.34-4.95), RR 1.27* (1.20-1.34), RD 0.18* (0.14-0.22) and the NNH was 5.56* (4.54-7.14) (*P<0.00001).
Severe ROP A total of 118 of 330 babies with SFI had severe ROP compared to 235 of 1951 babies with no SFI. The risk of severe ROP was significantly higher in the group that had SFI compared to the group that had no SFI (Figure 2 ). For VLBW infants, typical OR 4.06* (3.05-5.42), RR 2.74* (2.27-3.32), RD 0.22* (0.17-0.27) and the NNH was 4.54* (3.70-5.88) (*P<0.00001).
Discussion
This is the first meta-review conducted on the association of ROP and severe ROP and SFI in VLBW infants and it clearly indicates Fungal infection and retinopathy of prematurity SK Bharwani and R Dhanireddy that SFI is significantly associated with the risk of developing all degrees of ROP and severe ROP both in individual studies and collectively in the meta-review. The strengths of this meta-review are the large number of studies, the large number of infants for the meta-analysis, the methodological rigor and the appropriate reporting of the review. In addition, the review has expressed results (OR, RR, RD, NNH) in terms of the likely harm or benefit which individual patients can expect. We tried to minimize information bias by contacting three authors. Point estimates and effect size of overall analysis appear very similar to those in individual studies giving credence to the central thesis that SFIs are associated with all degrees of ROP and severe ROP in VLBW infants.
This review has certain limitations. Individual studies were not amenable to quality assessment because there is no consensus on what features of an observational study affect quality. 24 The review that we present may be incomplete because of language bias. We cannot rule out publication bias, as we are unable to access any negative studies that did not get published, and since the funnel plots are difficult to draw significance from the number of current studies in the meta-review. Furthermore, it should be noted that not all ROP studies necessarily report incidence of SFI and similarly not all studies of SFI include ROP incidence. In addition, the studies only included infants with documented SFI. Whether there were any infants without SFI who may have had subclinical fungal infection and what effect that may have had on the studied outcomes is unknown and has not been reported in the included studies. Also, observational/retrospective studies when pooled and subjected to meta-analysis may lead to precise but spurious results. 25 All studies included were observational. There were no prospective randomized controlled trials available for inclusion due to ethical concerns in conducting such trials. Figure 1 Meta-graph of odds ratio (OR) of all ROP in SFI vs no SFI in VLBW infants (n, all patients with any ROP; N, total eligible patients in study). Figure 2 Meta-graph of odds ratio (OR) of severe ROP in SFI vs no SFI in VLBW infants (n, all patients with severe ROP; N, total eligible patients in study).
Fungal infection and retinopathy of prematurity SK Bharwani and R Dhanireddy Preventing SFIs may decrease the risk of any ROP and severe ROP in VLBW infants. Also, the current levels of strong association behoove the clinician taking care of premature babies to look for SFI vigilantly and treat it aggressively.
The current studies and review do not address the mechanism of the association between SFI and ROP nor does it prove any cause and effect. Future animal research is needed to elucidate the mechanisms (molecular markers, cytokines, growth factors etc.) in the appropriate models as to how does SFI cause ROP. There are hypotheses that explain the association between SFI and the development of ROP. Candida albicans is known to interact with vascular endothelial cells in a number of different ways. Its ability to induce phagocytosis, endothelial cell damage and release of cytokines and prostanoids by these cells is well documented. [25] [26] [27] Systemic candida infection may injure developing blood vessels in the retina, which stimulates proinflammatory cytokines, 22 making them more vulnerable to ultimately develop severe ROP. This injury to the vascular endothelium occurs at the cellular level and, in part, may explain why none of these infants have evidence of endophthalmitis on ophthalmology examination. In addition, systemic candidiasis in a mouse model has been shown to induce neovascularization in the kidney and the brain. 28 The exact mechanisms of induction of angiogenesis by C. albicans are unknown. It is possible that there may be an angiogenic substance that is produced by Candida species that may be responsible for the increased severity of ROP. It is not known if candidemia modulates the expression of known angiogenic factors, such as vascular endothelial growth factor, that have been implicated in the pathogenesis of ROP.
29,30
Summary
The meta-review of the eight studies taken together indicates that SFI is significantly associated with the risk of developing all degrees of ROP and severe ROP in VLBW infants.
